HRAS anticorps
Aperçu rapide pour HRAS anticorps (ABIN5700942)
Antigène
Voir toutes HRAS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Immunogène
- v-Ha-ras Harvey rat sarcoma viral oncogene homolog
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
HEK-293 cells were subjected to SDS PAGE followed by western blot with FNab04008( HRAS-Specific Antibody) at dilution of 1:300
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Date de péremption
- 12 months
-
-
- HRAS (HRas proto-oncogene, GTPase (HRAS))
-
Autre désignation
- HRAS
-
Poids moléculaire
- 21 kDa
-
Pathways
- Signalisation p53, Signalisation MAPK, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Hepatitis C, Autophagy, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling, BCR Signaling
Antigène
-